Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid
about
Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will playDrug Development in Alzheimer's Disease: The Contribution of PET and SPECTFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsImpact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionPredictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [CorrectedCerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Alzheimer DiseaseComparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.NG2 cells, a new trail for Alzheimer's disease mechanisms?Outcome markers for clinical trials in cerebral amyloid angiopathy.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's diseaseA blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study.Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment.Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer diseaseBrain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measuresIndependent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's diseaseA consensus in Korea regarding a protocol to reduce preanalytical sources of variability in the measurement of the cerebrospinal fluid biomarkers of Alzheimer's disease.Emerging β-amyloid pathology and accelerated cortical atrophy.Factors affecting Aβ plasma levels and their utility as biomarkers in ADNIShort-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects.Shapes of the trajectories of 5 major biomarkers of Alzheimer diseaseRecent advances in neuroimaging biomarkers in geriatric psychiatry.Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarkerComparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloidPittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.β-amyloid dynamics in human plasmaEffects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults.Cerebral amyloid PET imaging in Alzheimer's disease.Biomarker modeling of Alzheimer's disease.Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment.Biomarker modelling of early molecular changes in Alzheimer's disease.Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease.Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration.The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
P2860
Q24594531-92324D5A-DE8C-4017-97F5-591E46BDE8B2Q26749755-1F6A1C0E-7917-4723-A87D-C0A9E2E569AAQ26784569-D9834084-BFBF-499C-B09D-9CBA433E5565Q26801629-10CC971F-79E2-4C38-8E8E-B7EC11A1E96AQ27006831-2A0B584B-2F4C-4532-B8D4-6FACD03A3559Q27007436-B1D4BD71-44E1-4762-A5D0-0102499B2458Q28273817-F1E175E8-F639-424E-806F-55F9C99CC406Q30971403-9D28641F-6914-4E84-BA42-44017C8212FAQ33562441-42EA50BB-8E01-4E40-BC00-AE4F92B71FCAQ33604453-37F21EEF-CE47-47B3-BD6D-8A91F8D3966EQ33715573-84186967-EC1F-4F34-A153-9536CA8A632FQ33859442-D743BF00-5997-4132-9B6A-3220D1705530Q34065449-D564133F-534A-480D-96FD-A9C3363DB6BFQ34286393-AE014E87-C5DE-44DB-AEE9-E1B2EB6FDD05Q34341870-FF0A46BB-814B-4A43-8097-B177CD3370DBQ34462406-861AA5C8-8508-4C13-B3CC-14BCEABFF2ECQ34493453-459F5588-2B75-40F8-AAAF-616AAFBEC491Q35106592-7FA308FB-7E76-4CDE-98CC-E8EC99F55349Q35119389-F053619A-7397-4A91-BD09-543075336B58Q35291150-5057ED8A-81A9-4A8B-BB72-ABCED0CBE620Q35542164-BFC66080-7929-4CAB-9E57-5502BF6A1125Q35821382-3127DB54-2429-4C47-A44A-A9177FD8B857Q35948528-6DDECCF7-C481-4589-89F7-A79017B42CE9Q36407301-74A6FF72-A7A0-437F-9D6D-311E7134662FQ36677361-0462D575-0FE0-450D-B3E0-38B361DB72FCQ36885496-8E495E1A-687A-4CE6-A5D8-82D75265F299Q36998414-CE11F1C0-4CB4-4C6A-84B0-1263C13663FEQ37107044-8FAB3828-E661-48B0-9A3F-DACDB9A79852Q37198556-2652325D-72BC-49C3-85FE-9C102691F5D2Q37254727-8D68859F-D129-418E-B297-BFB8065B2552Q37395886-7702FEC4-03B1-43AB-8577-D0DFBD51C16BQ37459083-29934F38-A0F1-4FE8-9D92-2524A4A3F948Q37592824-0CB5737E-CE52-43AC-84B1-0FE464E31A0DQ37693146-A5DAFF69-3E18-45C8-A301-948488B9287CQ37976853-51562EF0-27B6-4FCA-92AA-1E71E9E3698FQ38166669-BED8DD1A-FF93-4FB6-80FC-1E4CB7F30FD1Q38269095-D1D75995-B24B-4FCC-8359-C87337A86051Q41140682-2AA2521E-2D79-486E-929A-F5ACE784E0B6Q41178085-09CF2F78-BD7F-472D-8A64-2BF1E8231758Q42363366-E85901DB-E0C4-421D-B5C1-FAD0798741CC
P2860
Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Transforming cerebrospinal flu ...... nd B units of brain Aβ amyloid
@ast
Transforming cerebrospinal flu ...... nd B units of brain Aβ amyloid
@en
Transforming cerebrospinal flu ...... nd B units of brain Aβ amyloid
@nl
type
label
Transforming cerebrospinal flu ...... nd B units of brain Aβ amyloid
@ast
Transforming cerebrospinal flu ...... nd B units of brain Aβ amyloid
@en
Transforming cerebrospinal flu ...... nd B units of brain Aβ amyloid
@nl
prefLabel
Transforming cerebrospinal flu ...... nd B units of brain Aβ amyloid
@ast
Transforming cerebrospinal flu ...... nd B units of brain Aβ amyloid
@en
Transforming cerebrospinal flu ...... nd B units of brain Aβ amyloid
@nl
P2093
P2860
P50
P1476
Transforming cerebrospinal flu ...... nd B units of brain Aβ amyloid
@en
P2093
Heather J Wiste
Leslie M Shaw
Prashanthi Vemuri
Stephen D Weigand
Vernon S Pankratz
P2860
P304
P356
10.1016/J.JALZ.2010.08.230
P407
P50
P577
2011-02-01T00:00:00Z